Rob Stein

Rick Slayman, who in March became the first living person to receive a kidney from a genetically modified pig, has died. One of his doctors talks about what was learned from the historic transplant.

The health officials say the country is ready to produce a vaccine against a worrisome flu virus that recently jumped from birds to cows and at least one person. But some experts are skeptical.

Scientists are developing artificial wombs to rescue babies who would die or end up severely disabled because they are born very prematurely. The research is generating excitement, but also concerns.

The FDA approved the first gene-editing treatment for a human illness — the first genetic therapy for the brutal blood disorder sickle cell disease.

Researchers report the first results from a study testing the revolutionary gene-editing technique known as CRISPR for cutting high cholesterol.

The Food and Drug Administration took a crucial step toward approving the first treatment using the revolutionary gene-editing technique known as CRISPR to treat sickle cell disease.

Advisers to the Food and Drug Administration meeting Tuesday paved the way for the first treatment of human disease using the gene-editing technique CRISPR. The agency has a December deadline.

Two scientists won the Nobel Prize in Physiology and Medicine played a crucial role in the development of the COVID-19 vaccines.

Hungarian-born biochemist Katalin Karikó and American immunologist Drew Weissman found that a chemical change to genetic code called mRNA eliminated a problematic side effect when used in vaccines.

Public health experts are urging people to take advantage of the fact that this year, for the first time, vaccines are available for three major respiratory viruses: flu, COVID and RSV.

Scientists in Japan are leaders in the development of new technology that could make sperm and eggs from practically any cell in the body. The results could transform human reproduction.

Scientists in Japan are at the forefront of one the most controversial areas of biomedical research: creating sperm and eggs in the laboratory from practically any cell in the body.

As COVID-19 cases rise in U.S., new boosters have started to arrive at pharmacies this week. Here's how protective the latest booster is, who should get it and how to schedule it with other vaccines.

Updated versions of the mRNA vaccines roll out this week. Experts say they offer good protection against current COVID variants. Who should get them, and when's the best time to roll up your sleeve?

A panel of doctors and scientists advising the Centers for Disease Control and Prevention voted to recommend that people 6 months of age and older get new COVID boosters this fall.

Vaccines for a fall immunization drive against COVID-19 just got the green light from the Food and Drug Administration. The agency says the vaccines can protect people, as hospitalizations tick up.

The latest shots could bolster immunity as a new COVID-19 wave rises, and the season for peak respiratory illnesses approaches.

The latest lab data suggests that a new COVID-19 booster will protect against a worrisome variant. (Story aired on All Things Considered on Sept. 5, 2023.)

Preliminary laboratory studies find antibodies from previous infections and vaccinations can neutralize the BA.2.86 variant. The findings bode well for new boosters on the way this fall.

Ahead of Labor Day weekend, here's an update on COVID in the U.S. — plus a look ahead to likely FDA approval of new COVID boosters and what could be a busy fall of vaccination for flu, RSV and COVID.